A randomized, double-blinded, placebo-controlled, phase I/II, dose-ranging study of the safety, reactogenicity, and immunogenicity of intramuscular inactivated influenza A/H5N1 vaccine [influenza A virus vaccine-H5N1] in healthy adults
Phase of Trial: Phase I/II
Latest Information Update: 22 Aug 2013
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype; Influenza A virus infections
- Focus Pharmacodynamics
- 13 Dec 2005 New trial record.